You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LAM

Showing 1 - 25 of 2,084
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Hypertension Trial in Boston (LAM-001)

Recruiting
  • Pulmonary Hypertension
  • Boston, Massachusetts
    Brigham and Women's Hospital
Apr 11, 2023

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

Frontotemporal Dementia Trial (LAM-002A)

No longer available
  • Frontotemporal Dementia
  • (no location specified)
Jul 29, 2022

COVID-19 Disease Trial in New Haven (Apilimod Dimesylate Capsule, Placebo)

Completed
  • COVID-19 Disease
  • Apilimod Dimesylate Capsule
  • Placebo
  • New Haven, Connecticut
    Yale University
Sep 15, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Iowa City, Baltimore, Boston (LAM-002A, Placebo)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Iowa City, Iowa
  • +2 more
Aug 10, 2022

Urine LAM to Eliminate NTM Sputum Screening

Recruiting
  • Cystic Fibrosis
  • urine lipoarabinomannan (LAM)
  • Denver, Colorado
    National Jewish Health
Apr 6, 2022

Next Generation LAM Assays and Molecular Diagnostics for

Not yet recruiting
  • Tuberculosis
    • (no location specified)
    Aug 24, 2023

    Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)

    Completed
    Has Results
    • Lymphangioleiomyomatosis (LAM)
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 18, 2022

    Study of the Disease Process of Lymphangioleiomyomatosis

    Recruiting
    • Lung Disease
    • +3 more
    • Toshibia Aquilion One CT
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Smoking Cessation, Motivation Trial in Hong Kong (Small Talk Motivational Interviewing)

    Not yet recruiting
    • Smoking Cessation
    • Motivation
    • Small Talk Motivational Interviewing
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    Nov 20, 2023

    LAM, Lymphangioleiomyomatosis Trial in United States (Sirolimus)

    Recruiting
    • LAM
    • Lymphangioleiomyomatosis
    • Los Angeles, California
    • +9 more
    Jan 11, 2022

    Lymphangioleiomyomatosis (LAM) Trial in Nashville (Glutamine)

    Completed
    • Lymphangioleiomyomatosis (LAM)
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Aug 10, 2021

    Oncology, Acute Myeloid Leukemia Trial in United States (Open Label LAM-003)

    Completed
    • Oncology
    • Acute Myeloid Leukemia
    • Open Label LAM-003
    • New Haven, Connecticut
    • +5 more
    Dec 17, 2021

    Internet Addiction Trial in Hong Kong (bCBTMI, Control)

    Recruiting
    • Internet Addiction
    • bCBTMI
    • Control
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    May 31, 2023

    Smoking Cessation Trial in Hong Kong ('Learning while serving' training program, Usual care)

    Active, not recruiting
    • Smoking Cessation
    • 'Learning while serving' training program
    • Usual care
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    May 31, 2023

    Drug Abuse Trial in Hong Kong (AA group, Control group)

    Recruiting
    • Drug Abuse
    • AA group
    • Control group
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    May 25, 2023

    Cannabis Trial in Hong Kong (A community-based network training program)

    Not yet recruiting
    • Cannabis
    • A community-based network training program
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    May 26, 2023

    Lymphangioleiomyomatosis Trial in Beijing (11C-Choline)

    Not yet recruiting
    • Lymphangioleiomyomatosis
    • Beijing, Dongcheng, China
      Peking union medical college hospital
    Oct 8, 2021

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in

    Recruiting
    • Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
    • Chronic Lung Allograft Dysfunction
    • San Francisco, California
      University of California, San Francisco
    Aug 28, 2023

    Kidney Failure, Chronic Trial (Lanthanum carbonate)

    Completed
    • Kidney Failure, Chronic
    • Lanthanum carbonate
    • (no location specified)
    Jun 18, 2021

    TB - Tuberculosis HIV Trial (Urinary LAM ELISA:)

    Completed
    • TB - Tuberculosis HIV
    • Urinary LAM ELISA:
    • (no location specified)
    Mar 23, 2021

    EFT for Adolescents With Cancer

    Active, not recruiting
    • Cancer
    • Testing of the EFT
    • Hong Kong, Hong Kong,China, Hong Kong
      Katherine Lam
    Mar 22, 2022

    Safety and Durability of Sirolimus for Treatment of LAM

    Recruiting
    • Lymphangioleiomyomatosis
    • Stanford, California
    • +19 more
    Jan 11, 2022

    Anxiety Symptoms Trial in Arlesheim (Bryophyllum 50 % Chewing Tablets)

    Recruiting
    • Anxiety Symptoms
    • Bryophyllum 50 % Chewing Tablets
    • Arlesheim, Basel Land, Switzerland
      Klinik Arlesheim
    Sep 5, 2022